Market research
3LP.F Columbia Care Inc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 502M
- P/E ratio
- Not available
- Analyst target
- 2.35
- Dividend yield
- 0.0%
- Beta
- 1.76
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA1973091079
- Market cap
- 502M
- P/E ratio
- Not available
- Analyst target
- 2.35
- Dividend yield
- 0.0%
- Beta
- 1.76
About
About Columbia Care Inc
Columbia Care Inc. engages in cultivation, manufacture, and provision of cannabis products and related services in the United States and internationally. The company offers spanning flower, edibles, oils, and tablets under the Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brand names. It holds licenses in 17 jurisdictions in the United States. The company was founded in 2012 and is headquartered in New York, New York.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 3LP.F discussion.
5 years, 5 months ago
Columbia Care Inc is currently in a long term downtrend where the price is trading 11.0% below its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.4.
Columbia Care Inc's total revenue rose by 228.3% to $76M since the same quarter in the previous year.
Its net income has dropped by 115.6% to $-56M since the same quarter in the previous year.
Finally, its free cash flow grew by 68.0% to $-10M since the same quarter in the previous year.
Based on the above factors, Columbia Care Inc gets an overall score of 3/5.